吉林早泄手术最好医院吉林龟头上有红点点不痛不痒,吉林哪家包皮检查医院比较好,吉林看包皮的医院,吉林男科医院网络咨询,吉林做包皮环切术医院哪家最好,吉林去哪里治早泄病,吉林前列腺炎怎么治疗才能好呢

HAWAII VOLCANOES NATIONAL PARK, HI (KGTV) -- They are photos almost too amazing to be real - people playing golf as an ash plume from the Kilauea volcano rises behind them. Since the beginning of May ash and lava have threatened homes on the big island, but that certainly hasn't deterred golfers. The United States Geological Survey said a recent lowering of the lava lake at the volcano's Halemaumau crater 'has raised the potential for explosive eruptions' at the volcano."RELATED:  518

GRAND RAPIDS, Mich. — As we get closer to a potential COVID-19 vaccine approval in the U.S., doctors are hoping the public actually gets the vaccine once it’s available.Recent polling from Pew Research shows about 60% of Americans say they would ‘definitely’ or ‘probably’ get a COVID-19 vaccine.Local infectious disease doctors tell WXMI that that number will be just enough to put a serious dent in infections, but the more immunity, the better.Dr. Andrew Jameson, the Division Chief for Infectious Disease at Mercy Health said, “I am optimistic for the first time in a while.”Dr. Jameson added that he’s seeing a bit of light at the end of a very long tunnel with a COVID vaccine approval potentially just days away.“I can tell you right now from what I’ve seen, from an efficacy standpoint, from a safety standpoint, I am going to be definitely getting the vaccine personally and I have zero issues of giving my family the vaccine when it’s available,” Dr. Jameson said.With two COVID-19 vaccines on deck for approval with the FDA, one from Pfizer and one from Moderna, Dr. Jameson is hoping that people feel confident in getting it once they’re able.“If we get about 60% of people immunized and then we also have the natural immunity out there giving us a little bit of extra help, I think that is going to be a huge impact,” Dr. Jameson said.Dr. Jameson said he also understands that people may be wary of such a new vaccine.“Unfortunately, we’ve had a fair amount of skepticism in the community about vaccines before all of this, and now in the setting of this being moved forward pretty quickly, I think there’s probably a little bit of a natural skepticism,” he said.He said the biggest reason he’s heard for not wanting the vaccine is that things are just moving too fast.“Before this, the fastest that we ever had a vaccine get from the beginning to the end to where people were getting it, was four years, and this one is going to be about 10 months,” Dr. Jameson said.Dr. Jameson called the trial and manufacturing process of both companies vaccines, ‘the most transparent’ he’s ever seen and trusts the FDA to leave no stone unturned before approval.“They get all the notes from the doctors, they get all the patient encounter visits from the sites that are doing the vaccine, so they actually get all of the raw data and re-interpret it and re-analyze it themselves for efficacy, so they don’t just believe what the drug manufacturers tell them,” he explained.He wants people to also understand potential vaccine side effects, to make sure they come back for their second dose. Both Moderna and Pfizer vaccines require two doses given several weeks apart to reach full effectiveness.“If I know that my arm is going to hurt, and I might have a headache, and I might feel run-down for a day or two, if I know that, it’s very different than if that’s a surprise to me,” he said.The FDA is scheduled to meet on Thursday to review the Pfizer vaccine and then again on Dec. 17 to look over Moderna’s vaccine.This story was first reported by Annie Szatkowski at WXMI in Grand Rapids, Michigan. 3109

GREEN BAY, Wisc. — A man was arrested for his seventh OWI after police say he threw stolen beer and meat out of his van with officers in pursuit. The Brown County Sheriff's Office received a call from a supermarket that Timothy Andrews, who was on their watch list for retail theft, was in the store. Authorities spotted Andrews inside a van in the parking lot and deputies say he claimed to have knives and gun when they approached him.Andrews refused to get out of the van, according to investigators, and sped away from the deputies, throwing stolen beer, meat and clothing out of the window during the high-speed chase. Authorities say the van lost control at least twice during the chase, as it weaved in and out of oncoming traffic on busy streets. "Pursuits are always a balance. You're always trying to balance public safety with the apprehension of the person. And in this case, this man was doing a lot of things," Brown County Sheriff's Capt. Dan Sandberg said. The van finally spun out of control and stopped on a residential street where the suspect was arrested. Andrews, 48, faces several charges in the case including 7th offense OWI, probation violation, obstructing an officer, shoplifting and retail theft.   1280

High school students across the country could soon receive training on how to stop bleeding during an incident like a school shooting, and the federal government is offering a big grant to make this happen.This week, Clay High School in Oregon, Ohio became one of the few schools to add Stop the Bleed kits in 90 classrooms, thanks to the proposal of student Nick McNeal.McNeal brought the idea to his school’s student government program, and after much persistence, his school passed out the kits to all teachers earlier this week."Now it's a matter of, how can we keep our kids safe in addition to education," says school principal James Jurski.Now, the Department of Homeland Security wants to make sure even more teachers and students are prepared to do what they can to minimize casualties in the event of a school shooting. Officials are offering .8 million to anyone who can come up with a trauma-training program that could be utilized on a national scale.The program, called “School-Age Trauma Training (SATT),” seeks to “deliver free to the public, lifesaving trauma training to high school age students for mass casualty events.”Jurski says in 2018, it's just a necessity that schools prepare for these situations, but he admitted it is frustrating that it has come to this.“Every teacher in the building went into education to educate students,” explains Jurski. “And I don't think there’s a time, at least when I went to school, where safety was even mentioned in our training. Now, it’s just become a way of life."Homeland Security officials will be taking grant submissions until Aug. 27. 1613

Holidays will look different this year for many Americans, with dinners outside, social distancing, or passing on family gatherings altogether. But several companies developing rapid at-home COVID-19 tests are hopeful that won't be the case next year. The goal is to make inexpensive, easy-to-use COVID tests that can deliver results in minutes, just like a pregnancy test. "For people to feel comfortable to associate with friends or family, there needs to be a testing methodology ideally that can be performed at home," said Tony Lemmo, CEO of the manufacturing company BioDot.The company's technology is being used by over 70 manufacturers worldwide making COVID-19 antigen, antibody, and PCR tests. Their automated platforms dispense nanoliter/picoliter amounts of reagent onto the tests accurately and fast.Lemmo says just one of their systems can support the production of roughly 100 million COVID-19 tests per year, helping to make high-volume production possible.“We knew we were going to be called on by customers to manufacture more equipment to provide them the ability to manufacture more tests," said Lemmo. To meet customer demand, BioDot increased staffing and built a new facility, compressing production time from months to weeks. The FDA recently authorized the first rapid at-home test that can deliver results in 30 minutes, eliminating the need for a lab to test the sample. But the molecular single-use test will only be available to patients with a doctor's prescription who are suspected of being infected with COVID-19.Companies developing tests hope the FDA will soon authorize another at-home testing tool: the rapid antigen test.These inexpensive tests provide results within minutes, and companies developing them say millions could be sold without a doctor's referral.“From what we’re hearing, it’s really just a matter of possibly months before there’s at least sufficient data to be able to support an at-home use of a test like an antigen test," said Lemmo.Lemmo says if authorized by the FDA, manufacturers could make millions of these tests in a matter of months. But antigen tests are less accurate, and the FDA wants to ensure they'll be simple enough for people to use at home. There are also concerns over how the data will be reported to health authorities. “I think any at-home testing or massive rollout of a test into the communities needs to be done very carefully and with a lot of education around it," said Clinical Lab Director Melissa Miller. Dr. Miller is a professor of pathology and laboratory medicine at the University of North Carolina Chapel Hill and Medical Director for the Clinical Microbiology Lab for the Medical Center.She worries the inaccuracies of these tests could eventually lead the public to lose trust in all testing. “Even at 98 percent specificity, which is very, very high. That means you’re going to have a false positive two out of every 100. If you started testing a hundred million people, this is millions of people who have a false-positive test," said Dr. Miller. She says this could lead to healthy people isolating and missing work or school unnecessarily, and false-negative results could give people a false sense of security. “These rapid antigen tests were pushed out to skilled nursing facilities; this is a very high-risk patient population. This is actually where you want a very accurate test," said Dr. Miller. She says it’s unclear how well antigen tests detect the virus in asymptomatic patients but agrees more data is needed to figure that out.“It might make more sense for K-12 schools, or even college settings, where there’s less risk for a poor outcome if you have a false positive or a false negative," said Dr. Miller. But with a growing demand for convenient at-home testing, manufacturers are hopeful that in the months ahead, the FDA will soon open the door to new solutions. 3889